| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
|
|
|
|||||||
|
|||||||||
a Palmetto Health Alliance/University of South Carolina, Columbia
Correspondence: Ihab Hajjar, Clinical Assistant Professor, Department of Internal Medicine, Division of Geriatrics, Palmetto Health Alliance/University of South Carolina, 9 Medical Park, Suite 230, Columbia, SC 29203 E-mail: ihab.hajjar{at}palmettohealth.org.
Background. Previous evidence suggests that treatment with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors (statins) has a positive impact on dementia. We decided to investigate the association between the use of statins and the prevalence of dementia and statins' impact on the progression of cognitive impairment.
Methods. This is a case-control and a retrospective cohort study of a community-based ambulatory primary care geriatric practice. We included a convenience sample of all patients (N = 655, mean age 78.7 ± 0.3 years, 85% Caucasian, 74% women) with hypercholesterolemia or dementia, or using statins. We compared those using statins with those who do not with respect to the clinical diagnosis of dementia and its subtypes and the progression of cognitive impairment.
Results. At the initial visit, 35% had dementia, and 17% were using statins. After covariate adjustments, patients on statins were less likely to have dementia (odds ratio [OR] for dementia based on composite definition = 0.23; 95% confidence interval [CI] [0.1–0.56], p = .001, OR Alzheimer's disease = 0.37; 95% CI [0.19–0.74], p = .005, OR vascular dementia = 0.25; 95% CI [0.08–0.85], p = .027). At follow-up, patients on statins showed an improvement on their Mini-Mental Status Examination score by 0.7 ± 0.4 compared to a decline by 0.5 ± 0.3 in controls, p = .025 (OR for no change or improvement on statins = 2.81; 95% CI [1.02–8.43], p = .045) and scored higher on the Clock Drawing Test (difference of 1.5 ± 0.1, p = .036).
Conclusions. The use of statins is associated with a lower prevalence of dementia and has a positive impact on the progression of cognitive impairment.
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
|
|
 |
|
  T. D. Rea, J. C. Breitner, B. M. Psaty, A. L. Fitzpatrick, O. L. Lopez, A. B. Newman, W. R. Hazzard, P. P. Zandi, G. L. Burke, C. G. Lyketsos, C. Bernick, and L. H. Kuller Statin Use and the Risk of Incident Dementia: The Cardiovascular Health Study Arch Neurol, July 1, 2005; 62(7): 1047 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Reitz, J. Luchsinger, M. -X. Tang, J. Manly, and R. Mayeux Impact of plasma lipids and time on memory performance in healthy elderly without dementia Neurology, April 26, 2005; 64(8): 1378 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Zandi, D. L. Sparks, A. S. Khachaturian, J. Tschanz, M. Norton, M. Steinberg, K. A. Welsh-Bohmer, J. C. S. Breitner, and for the Cache County Study Investigators Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?: The Cache County Study Arch Gen Psychiatry, February 1, 2005; 62(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reitz, M.-X. Tang, J. Luchsinger, and R. Mayeux Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia Arch Neurol, May 1, 2004; 61(5): 705 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bjorkhem and S. Meaney Brain Cholesterol: Long Secret Life Behind a Barrier Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 806 - 815. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. B. Chauhan Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease J. Lipid Res., November 1, 2003; 44(11): 2019 - 2029. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Suryadevara, S. G. Storey, W. S. Aronow, and C. Ahn Association of Abnormal Serum Lipids in Elderly Persons With Atherosclerotic Vascular Disease and Dementia, Atherosclerotic Vascular Disease Without Dementia, Dementia Without Atherosclerotic Vascular Disease, and No Dementia or Atherosclerotic Vascular Disease J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2003; 58(9): M859 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Shumaker, C. Legault, S. R. Rapp, L. Thal, R. B. Wallace, J. K. Ockene, S. L. Hendrix, B. N. Jones III, A. R. Assaf, R. D. Jackson, J. Morley Kotchen, S. Wassertheil-Smoller, and J. Wactawski-Wende Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial JAMA, May 28, 2003; 289(20): 2651 - 2662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ghosh and W. S. Aronow Utilization of Lipid-Lowering Drugs in Elderly Persons With Increased Serum Low-Density Lipoprotein Cholesterol Associated With Coronary Artery Disease, Symptomatic Peripheral Arterial Disease, Prior Stroke, or Diabetes Mellitus Before and After an Educational Program on Dyslipidemia Treatment J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): M432 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Banks and J. E. Morley Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M314 - 321. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Morley Editorial: Hot Topics in Geriatrics J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2003; 58(1): M30 - 36. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Aronow Guest Editorial: Should Hypercholesterolemia in Older Persons Be Treated to Reduce Cardiovascular Events? J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M411 - 413. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| All GSA journals | The Gerontologist |
| Journals of Gerontology Series B: Psychological Sciences and Social Sciences | |
